OXO bridged diazepan orexin receptor antagonists
US8263586B2 · kind B2 · utility
19Cited by
2References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 14, 2008 |
| Grant date | Sep 11, 2012 |
| Priority date | — |
| Expiry date | Apr 29, 2029 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to oxo bridged diazepan compounds which are antagonists of orexin receptors, and which are useful in the treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which orexin receptors are involved.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.